A Kalman Filter -based algorithm provide smoother and more predictable description of AD staging
Having previously shown that the Self-Administered Gerocognitive Examination (SAGE) is a cognitive assessment for screening individuals with Mild Cognitive Impairments (MCI), subjective memory complaints, or early dementia (44, 45) ; we first recruited patients whose MMSE and SAGE scores determined they had MCI or mild, moderate, or severe AD ( fig. S1A) . Data sheets of MMSE and SAGE scores are listed in table S5.
In the SAGE scoring system, lower scores are associated with more advanced stages of AD.
These cognitive measures can be utilized as inputs for the KF-based algorithm to diagnose disease states. When compared to the staging evaluation directly using cognitive assessment scores, the prediction that was obtained by processing these assessment scores through the KF showed a smoother and more predictable description of AD stages ( fig.   S1B ). The computational efficiency and prediction capabilities observed from the KF derived diagnosis were due to the predictive nature of its recursive algorithm (32, 33) .
fig. S1. Comparisons between cognitive assessment evaluations and the KF-based predictions of AD progression. (A) The association between different cognitive tests (MMSE and SAGE) with MCI and AD stages. Data is represented as mean ± S.D. Sample number n = 49. (B) MCI and AD stages were converted into ordinal variables by assigning ranks of 1 to 4, where the MCI stage is indicated by 1 and severe AD is indicated by 4.
Comparisons between cognitive assessment evaluations and the KF-based predictions of AD progression are shown. KF-based algorithm provided smoother and more predictable description of AD staging.
Control experiments regarding the influence of a freeze-thaw cycle on the particle aggregation fig. S2. Synthesized Aβ was used to show the influence of a freeze-thaw cycle on the peptide and protein particle aggregation. Sample pre-experimental centrifugation procedures were the same as described in Methods section for human CSF samples. (A,B) Representative AFM images of aggregates formed without and with a freeze-thaw cycle treatment. Particle diameters in both cases were measured. (C) Date of the particle diameter in both cases showed no significant different between two groups. These results demonstrated that a freeze-thaw cycle did not change the aggregation of synthesized Aβ.
The different aggregation between human CSF and synthesized Aβ provided clues leading to the pathological protein components inside patients' CSF.
Aβ-embedded aggregates are observed to be longer as fibrillar shape in AD cases.
Prior to characterizing the nano-scale properties of the CSF's protein components, we first evaluated the existence, abundance, and localization of the AD hallmarks: Aβ and tau ( fig.   S3 ). In healthy patients, large Aβ aggregates were not observed; however, increasing AD severity coincided with increasing Aβ(1-42) aggregation ( fig. S3A,B) . Negative controls labeled with rabbit IgG antibody ( fig. S3C ) showed few green-labeled objects, indicating that non-specific binding of the antibodies did not obstruct the results. Interestingly, as disease severity increased, Aβ-embedded aggregates had a distinct shape that was marked by an increase in length, but not width ( fig. S3D ). Similar to previous findings showing that Aβ fibrillization occurs during the disease progression (17), we found that Aβ-embedded protein aggregates tended to take on a longer, fibrillar shape, in disease cases. Thus, the length of aggregates could be used as an indicator to distinguish certain disease stages.
Unlike Aβ(1-42), we found that tau was not present in large aggregates ( fig. S4) . Instead, there were more hollow areas in disease groups (in which there is no tau, shown as black spots inside large green areas), a trend that increased, but not significantly, with disease progression. These results confirmed previous findings demonstrating that Aβ and tau proteins (12, 23) undergo morphological aggregation and conformational changes in AD patients; however, it also highlighted how nano-morphological changes to these proteins can serve as physical biomarkers. Aβ-embedded aggregates tend to be longer as fibrillar shape in AD cases. All data are presented as box plots. Sample number n = 34. One-way ANOVA test was performed, alpha = 0.05. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001. there is no significant difference between healthy and disease groups.
Case studies: Age and gender related effects on nano-mechanics of CSF protein components
Age and gender related case studies were conducted to evaluate the effects, as well as mitigate possible influences, among populations. As shown in fig. S5A , two female subjects with a 14 year age gap were analyzed. Based on the distribution of experimental data, CSF protein components from the older subject showed a relatively higher Young's modulus.
However, no statistically significant difference was observed between the two subjects. In fig. S5B , two subjects with the same age but different gender were analyzed. Male case showed a relatively higher Young's modulus, but there was no significant difference. In fig.   S5C , four male subjects of a similar age were analyzed. Young's modulus had an increasing trend during the disease development. Although statistical significance was limited, these case studies provided the trends between the nano-mechanics of CSF components and the patient demographics such as age and gender. Larger studies may help determine if these population measures can be integrated into the KF-based algorithm. fig. S5 . Age-and gender-related analysis. For each image, case name is expressed as a subject number (for clinical record) followed by gender and age. "M" and "F" represents "Male" and "Female" respectively. An unpaired two-tail Student's t test was performed (for the groups which have unequal population variances, Welch's correction was applied). (A)
To evaluate age effects, two female subjects with 14 years age gap were analyzed. Although there was no significant difference between these two subjects, older subject showed an increasing trend of Young's modulus. (B) For evaluating gender effects, one male and one female subject with the same age were analyzed. Male case showed relatively higher Young's modulus. (C) 4 male subjects with similar ages were analyzed. Young's modulus showed an increasing trend along with the disease progression.
Particle size measurement of CSF protein components using HMI fig. S6 . Particle size, shown as the size of white spots. Although there were more large particles in severe AD case, the comparison between each group showed no significant difference. All data are presented as box plot. One-way ANOVA test was performed.
Case study: Accuracy of KF-based diagnosis using nano-scale physical biomarkers
In order to demonstrate the correlation between cognitive assessments and physical biomarkers, data from three individuals were utilized to show the dynamics in AD progression described by both cognitive assessments and physical biomarkers. The changes of both data fit well and showed good correlations between them.
fig. S7. Dynamics of nanocharacterization and cognitive assessment data in AD
progression. Correlations between measurements from three individual patients (P1, P2, P3) and nanocharacterization data was shown.
To demonstrate the accuracy of KF-based diagnosis for determining the AD stages of individual patients, we utilized cognitive assessment scores (MMSE, SAGE) from a female subject and compared with the KF-based diagnosis using both nano-scale physical biomarkers and cognitive assessments scores as inputs. As shown in fig. S8 , both the MMSE and SAGE determined stages deviated away from doctor's comprehensive staging for this patient, while the KF-based diagnosis fit well with doctor's judgments. The results from this case study showed that the KF-based computational algorithm could be a more sensitive and predictable approach to determine AD stages. A total of 34 subjects were used (10 subjects from healthy group, mild AD group and moderate AD group respectively; 4 subjects from severe AD group). A total of 30 subjects were used (8 subjects from healthy group, mild AD group and moderate AD group respectively; 6 subjects from severe AD group). Anti-Aβ(1-42) antibody labeling 4 images were obtained and processed, totally 40 particles were measured (10 in each image)
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